Humana Inc. (HUM)
255.31 USD +7.97 (+3.22%) Volume: 1.88M
Humana Inc.’s stock price stands strong at 255.31 USD, marking a promising increase of +3.22% this trading session, driven by a robust trading volume of 1.88M. With a positive year-to-date (YTD) change of +0.63%, Humana (HUM) continues to demonstrate solid performance in the market.
Latest developments on Humana Inc.
Humana Inc. stock experienced fluctuations today despite daily gains, with some investors showing interest in the company while others reduced their positions. The Humana Foundation CEO, Tiffany Benjamin, was recently named to the TIME100 Philanthropy List, showcasing the company’s commitment to social impact. Additionally, Zacks Research has a positive forecast for Humana’s Q2 earnings, indicating potential growth ahead. Investors like Systematic Financial Management LP and Meridiem Capital Partners LP have also shown confidence in the company by investing millions of dollars in its stock. Despite facing some challenges in the market, Humana Inc. continues to attract attention from various financial institutions and investors.
Humana Inc. on Smartkarma
Analysts on Smartkarma, like those from Value Investors Club, have been covering Humana Inc, a company that provides Medicare Advantage plans to around 6 million members. The research report published on Monday, Oct 28, 2024, highlighted how Humana offers government health insurance for seniors through private insurers. The analysts lean bull on Humana, emphasizing the company’s focus on value-based care relationships with providers and preventative treatment to provide efficient and high-quality care.
The report mentions that Medicare Advantage plans limit provider networks and treatments while incentivizing cost-saving behavior. It also emphasizes the shift towards paying for outcomes rather than the volume of services provided. This information, sourced from publicly available sources, serves as general informational purposes. Investors seeking insights into Humana Inc‘s operations can refer to the detailed research reports published by independent analysts on Smartkarma.
A look at Humana Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Humana Inc. has received favorable Smart Scores in key areas such as value and dividend, indicating a positive long-term outlook for the company. With strong scores in these categories, Humana is poised to provide good returns for investors while also offering attractive dividend payouts. While the company’s growth, resilience, and momentum scores are slightly lower, the overall outlook remains solid due to its strength in value and dividends.
As a managed health care company serving members in the United States and Puerto Rico, Humana Inc. offers a range of health care services through various plans and products. With a focus on providing coordinated care to employer groups, government plans, and individuals, Humana plays a crucial role in the healthcare industry. Despite facing some challenges in growth, resilience, and momentum, the company’s strong performance in value and dividends bodes well for its long-term prospects.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
